Article thumbnail

Genome-Wide Association Analysis of Autoantibody Positivity in Type 1 Diabetes Cases

By Vincent Plagnol, Joanna M. M. Howson, Deborah J. Smyth, Neil Walker, Jason P. Hafler, Chris Wallace, Helen Stevens, Laura Jackson, Matthew J. Simmonds, , Polly J. Bingley, Stephen C. Gough and John A. Todd

Abstract

The genetic basis of autoantibody production is largely unknown outside of associations located in the major histocompatibility complex (MHC) human leukocyte antigen (HLA) region. The aim of this study is the discovery of new genetic associations with autoantibody positivity using genome-wide association scan single nucleotide polymorphism (SNP) data in type 1 diabetes (T1D) patients with autoantibody measurements. We measured two anti-islet autoantibodies, glutamate decarboxylase (GADA, n = 2,506), insulinoma-associated antigen 2 (IA-2A, n = 2,498), antibodies to the autoimmune thyroid (Graves') disease (AITD) autoantigen thyroid peroxidase (TPOA, n = 8,300), and antibodies against gastric parietal cells (PCA, n = 4,328) that are associated with autoimmune gastritis. Two loci passed a stringent genome-wide significance level (p<10−10): 1q23/FCRL3 with IA-2A and 9q34/ABO with PCA. Eleven of 52 non-MHC T1D loci showed evidence of association with at least one autoantibody at a false discovery rate of 16%: 16p11/IL27-IA-2A, 2q24/IFIH1-IA-2A and PCA, 2q32/STAT4-TPOA, 10p15/IL2RA-GADA, 6q15/BACH2-TPOA, 21q22/UBASH3A-TPOA, 1p13/PTPN22-TPOA, 2q33/CTLA4-TPOA, 4q27/IL2/TPOA, 15q14/RASGRP1/TPOA, and 12q24/SH2B3-GADA and TPOA. Analysis of the TPOA-associated loci in 2,477 cases with Graves' disease identified two new AITD loci (BACH2 and UBASH3A)

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3150451
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2001). A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetes.
  2. (2005). A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.
  3. (2009). A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.
  4. (2007). A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic Tlymphocyte-associated antigen-4 gene.
  5. (1971). ABO blood groups in patients with gastric carcinoma associated with pernicious anaemia.
  6. (1997). Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes care 20:
  7. (1998). Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
  8. (2008). Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2.
  9. (2006). B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends in endocrinology and metabolism:
  10. (2003). B lymphocyte activation during cognate interactions with CD4+ T lymphocytes: molecular dynamics and immunologic consequences. Seminars in immunology 15:
  11. (1957). Blood groups and susceptibility to disease: a review.
  12. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.
  13. (2009). Detecting shared pathogenesis from the shared genetics of immune-related diseases.
  14. (1965). Distribution of ABO blood groups in patients with pernicious anemia, gastric carcinoma and gastric carcinoma associated with pernicious anemia. The New England journal of medicine 273:
  15. (2010). Expression of the Autoimmune Susceptibility Gene
  16. (2002). Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes.
  17. (2010). Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany. Experimental and clinical endocrinology & diabetes 118:
  18. (2009). Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arteriosclerosis, thrombosis, and vascular biology 29:
  19. (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.
  20. (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci.
  21. (2009). Genomewide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
  22. (1996). Helicobacter pylori infection and blood group antigens: lack of clinical association. The American journal of gastroenterology 91:
  23. (1996). HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus.
  24. (2002). Humoral betacell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. American journal of medical genetics 115:
  25. (2008). Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. Journal of immunology (Baltimore, Md :
  26. (2000). Increased Inflammatory Responses of Persons of Blood Group O to Helicobacter pylori.
  27. (2010). Multiple common variants for celiac disease influencing immune gene expression.
  28. (2008). Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women.
  29. (1990). Pinchera A
  30. (1999). Prevalence of beta-cell and thyroid autoantibody positivity in schoolchildren during three-year follow-up.
  31. (2008). Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study.
  32. (2010). Recent advances in the genetics of systemic lupus erythematosus. Expert review of clinical immunology 6:
  33. (2010). Risk of Gastric Cancer and Peptic Ulcers in Relation to ABO Blood Type: A Cohort Study.
  34. (2009). Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. The New England journal of medicine 361:
  35. (2008). Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. The Journal of clinical endocrinology and metabolism 93:
  36. (2002). Serum TSH, T(4), and thyroid antibodies in the United States population
  37. (2009). Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL2RA on immune responses.
  38. (2008). Statistical independence of the colocalized association signals for type 1 diabetes and RPS26 gene expression on chromosome 12q13.
  39. (1965). Studies of parietal cell antibody in pernicious anemia.
  40. (1998). The Autoimmune Diseases,
  41. (2009). The effect of the MHC locus on autoantibodies in type 1 diabetes.
  42. (1993). Transfer of Type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID).
  43. (2007). Wellcome Trust Case Control Consortium